Irish pharma wary of 'detailed' guidelines for health technology assessment
This article was originally published in Scrip
Executive Summary
Ireland's Health Information and Quality Authority (HIQA), has published new guidelines on economic evaluations of health technologies. Although there are positive aspects for pharma companies, industry will have to work closely with authorities to ensure they do not become "overly cumbersome and slow down access to medicines," Brian Murphy, director of commercial affairs at the Irish Pharmaceutical Healthcare Association (IPHA), told Scrip.